Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan · Delayed Price · Currency is TWD 145.50
-4.50 (-3.00%)
At close: Mar 3, 2026
TPEX:6712 Market Cap
TPEX:6712 has a market cap or net worth of 12.75 billion as of March 3, 2026. Its market cap has decreased by -13.18% in one year.
Market Cap
12.75B
Enterprise Value
12.43B
Revenue
1.01B
Ranking
n/a
PE Ratio
24.69
Stock Price
145.50
Market Cap Chart
Since October 26, 2018, TPEX:6712's market cap has increased from 5.10B to 12.75B, an increase of 150.11%. That is a compound annual growth rate of 13.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 12.75B | -11.28% |
| Dec 31, 2025 | 14.37B | 1.47% |
| Dec 31, 2024 | 14.16B | -1.25% |
| Dec 29, 2023 | 14.34B | -4.57% |
| Dec 30, 2022 | 15.02B | 15.46% |
| Dec 30, 2021 | 13.01B | 32.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunmax Biotechnology | 21.57B |
| EirGenix | 18.52B |
| AP Biosciences | 15.15B |
| TaiMed Biologics | 14.04B |
| Tanvex BioPharma | 12.87B |
| Medigen Vaccine Biologics | 11.90B |
| TCM Biotech International | 11.87B |
| Gongwin Biopharm Holdings | 9.86B |